Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data? (Q33890570)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

3 references

19 March 2019

24 March 2019

20 August 2019

Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data? (English)

1 reference

Europe PubMed Central

29 July 2017

pharmacotherapy

0 references

3 references

19 March 2019

24 March 2019

20 August 2019

physiological phenomenon

1 reference

20 August 2019

object named as

Carl A Roberts

1

0 references

author name string

Paul Christiansen

2

1 reference

Europe PubMed Central

29 July 2017

Jason C G Halford

3

1 reference

Europe PubMed Central

29 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 April 2017

1 reference

Europe PubMed Central

29 July 2017

1 August 2017

3 references

19 March 2019

24 March 2019

20 August 2019

Acta Diabetologica

4 references

Europe PubMed Central

29 July 2017

19 March 2019

24 March 2019

20 August 2019

54

1 reference

Europe PubMed Central

29 July 2017

715-725

1 reference

Europe PubMed Central

29 July 2017

8

1 reference

Europe PubMed Central

29 July 2017

copyright license

Creative Commons Attribution 4.0 International

3 references

Europe PubMed Central

19 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

20 August 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1007/s00592-017-0994-x

0 references

Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Meal size is a critical driver of weight gain in early childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-cont

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

NICE-Accredited Commissioning Guidance for Weight Assessment and Management Clinics: a Model for a Specialist Multidisciplinary Team Approach for People with Severe Obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Genetic studies of body mass index yield new insights for obesity biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Appetite and growth: a longitudinal sibling analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Satiety mechanisms in genetic risk of obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Power failure: why small sample size undermines the reliability of neuroscience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Impulsivity and inhibitory control deficits are associated with unhealthy eating in young adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Obesity, a health burden of a global nature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

GLP-1, the gut-brain, and brain-periphery axes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Multicenter, placebo-controlled trial of lorcaserin for weight management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Body mass correlates inversely with inhibitory control in response to food among adolescent girls: an fMRI study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Pharmacological management of appetite expression in obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

The FTO gene rs9939609 obesity-risk allele and loss of control over eating

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Development and validation of the mindful eating questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Naltrexone for the treatment of obesity: review and update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Evaluating the Power of Food Scale in obese subjects and a general sample of individuals: development and measurement properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

An obesity-associated FTO gene variant and increased energy intake in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

The FTO gene and measured food intake in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Obesity associated genetic variation in FTO is associated with diminished satiety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Measuring 'expected satiety' in a range of common foods using a method of constant stimuli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Resistance and susceptibility to weight gain: individual variability in response to a high-fat diet

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Meta-analysis: pharmacologic treatment of obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Routes to obesity: phenotypes, food choices and activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Bupropion sustained release and smoking cessation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Overconsumption as a cause of weight gain: behavioural-physiological interactions in the control of food intake (appetite).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Psychological effects of dieting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5504125

5 July 2018

Differences in attention to food and food intake between overweight/obese and normal-weight females under conditions of hunger and satiety.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Dieting and food craving. A descriptive, quasi-prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Rational design of a combination medication for the treatment of obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Eating on impulse: the relation between overweight and food-specific inhibitory control.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake

1 reference

https://api.crossref.org/works/10.1007%2FS00592-017-0994-X

21 January 2018

Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/28421338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00592-017-0994-X

1 reference

Europe PubMed Central

29 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33890570&oldid=1960250080"